Feature

High hopes

Science  04 Jul 2014:
Vol. 345, Issue 6192, pp. 18-23
DOI: 10.1126/science.345.6192.18

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

Albert Hofmann, the Swiss chemist who discovered LSD and psilocybin, believed that these psychedelic drugs might be useful in treating mental illness; the company he worked for, Sandoz, sent them to doctors around the world for experimentation in the 1950s and '60s. But then, the drugs fell from grace, and most of the research was stopped. Now, researchers have rediscovered psychedelic drugs for their unmatched ability to alter the way the brain processes information, and they are studying them as possible treatments for depression, addiction, anxiety, cluster headaches, and other disorders. But this remains a contentious field, and the scientists studying these drugs face many difficult questions.